Skip to content

Early Adolescent Skills for Emotions (EASE) for young adolescents in Lebanon

Early Adolescent Skills for Emotions (EASE) in the treatment of psychological distress for young adolescents in Lebanon: A randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN75375136
Enrollment
445
Registered
2019-03-11
Start date
2019-06-01
Completion date
Unknown
Last updated
2022-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Psychological distress Mental and Behavioural Disorders

Interventions

Adolescents in participating communities in Lebanon are randomised to the following two conditions. 1. The Early Adolescent Skills for Emotions (EASE) program. This is a group psychological intervent

Sponsors

War Child Holland
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 10 and 14 years; 2. Reside with a caregiver who is able to provide consent; 3. Able and willing to commit to attending the weekly EASE sessions; 4. Screens positive for psychological distress during screening (using 17 item PSC). 5. Children of any nationality and background will be eligible.

Exclusion criteria

Exclusion criteria: 1. Unaccompanied minor; 2. Caregiver is not a family member, as they would not be able to provide legal consent; 3. Significant cognitive impairment or severe neurological impairments or developmental difficulties as determined by caregiver-report during screening, where this would impair their ability to participate in a group programme; 4. Imminent risk of suicide; 5. Currently married.

Design outcomes

Primary

MeasureTime frame
Psychological distress, as assessed by the Paediatric Symptom Checklist 35 (PSC-35) youth-report. This will be assessed at baseline (T0), post-intervention (T1), 3-month follow-up (T2), and 12-month follow-up (T3). The primary outcome timepoint is specified as T2.

Secondary

MeasureTime frame
All secondary outcomes will be assessed at T0, T1, T2 and T3. The primary outcome timepoint is specified as T2. 1. Adolescent-reported outcomes 1.1 Symptoms of depression- measured using the 9-item adolescent version of the Patient Health Questionnaire (PHQ-A). 1.2 Symptoms of traumatic stress- measured using the 13-item Children’s Revised Impact of Event Scale (CRIES-13). 1.3 Impairment of Daily Functioning- measured using a questionnaire was developed specifically for this study. It consists of 10 items pertaining to the level of impairment experienced with important daily activities; updated 19/06/2019: It consists of 9 items pertaining to the level of impairment experienced with important daily activities. 1.4 Wellbeing - measured using the 14-item Warwick Edinburgh Mental Wellbeing Scale (WEMWBS). 1.5 Child Use of Coping Strategies- measured via the 7-item Strategy Use Questionnaire (SUQ) developed specifically for the trial 2. Caregiver-reported outcomes 2.1 Caregiver-reported child psychological distress- measured by the PSC35 caregiver-version. 2.2 Caregiver level psychological distress- measured using the Kessler Psychological Distress Scale (K6) 2.3 Parenting- measured using the Alabama Parenting Questionnaire-42 (APQ42) 2.4 Caregiver Use of Coping Strategies- measured via the 8-item Strategy Use Questionnaire (SUQ) developed specifically for the trial Where a caregiver has multiple children in the study, the APQ42, K6, and caregiver SUQ will only be completed once by the caregiver, while the caregiver-report PSC-35 will be completed separately for each child. 3. Mediator: Mechanisms of treatment, measured using the SUQ child and parent versions. 4. Moderators: The study is not powered for moderation effects, however, we will conduct exploratory analyses of potential moderators, which may include: 4.1 Child exposure to potentially traumatic events, measured at T0 via caregiver report, using a trauma checklist contextually developed for this sit

Countries

Lebanon, Netherlands

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 2, 2026